Table 2.
UVEAL | CUTANEOUS |
---|---|
606 cases/year in Europe | 100,000 cases/year in Europe |
Mainly liver metastasis | Metastasis in various organs |
GNAQ or GNA11 gene mutations | BRAF or NRAS gene mutations |
Monosomy 3 in 50% of tumors | Monosomy 3 rarely occurring |
0.8–5% positive responsiveness to immunotherapy | 20–60% positive responsiveness to immunotherapy |